FitLife Brands, Inc. Common Stock (FTLF) — Analysis Summary
FitLife Brands, Inc. Common Stock (FTLF) has a market cap of $86.68M with year-over-year revenue growth of +26.4%. Net margin stands at 7.8%. The stock trades at a P/E ratio of 13.9.
Key Takeaways
- Revenue changed +26.4% year-over-year
- Net margin of 7.8%
- P/E ratio of 13.9
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, FTLF posted revenue growth of +26.4% and trades at a P/E of 13.9.
FitLife Brands, Inc. Common Stock (FTLF)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees
81
Headquarters
OMAHA, NE
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.